MASHINIi

Dogwood Therapeutics, Inc..

DWTX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Dogwood Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for the treatment of cancer. The company's pipeline includes preclinical programs targeting various cancer indications. Dogwood Therapeutics utilizes its propr...Show More

Ethical Profile

Mixed.

Dogwood Therapeutics (DWTX.US) focuses on developing treatments for debilitating conditions like fibromyalgia, neuropathic pain, cancer pain, and long-COVID, aiming to improve public health. While their mission is inherently positive, critics point to potential tensions between patent protection and drug affordability or access for vulnerable populations. The company maintains a cybersecurity risk management program, including employee training and annual vendor control reviews, though specific metrics are not publicly available. Dogwood Therapeutics, formerly Virios Therapeutics, changed its name in October 2024. Information on fair labor practices, ethical sourcing, animal welfare, and environmental impact is currently limited.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect50
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Dogwood Therapeutics, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Dogwood Therapeutics, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

50

Dogwood Therapeutics, Inc. offers a comprehensive package of employee welfare benefits, including health insurance, dental insurance, vision insurance, and short-term and long-term disability.

1
Executive officers participate on the same basis as other full-time employees.
2
As of December 31, 2024, the company had 12 full-time employees.
3
All employees are covered by these benefits, indicating 100% health insurance coverage for its full-time workforce.

Fair Trade & Ethical Sourcing

0

No evidence available to assess Dogwood Therapeutics, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No evidence available to assess Dogwood Therapeutics, Inc. on Honest & Fair Business.

Kind to Animals

0

The provided articles focus on Dogwood Therapeutics' clinical trial data, financial updates, and drug development pipeline.

1
No information is available regarding the company's animal testing policies, the volume of animals used in testing, investment in animal-free alternatives, humane certifications for operations, ethical sourcing of animal-derived inputs, or participation in animal welfare initiatives.
2
Therefore, no KPIs related to the 'Kind to Animals' value can be scored based on the evidence provided.

No War, No Weapons

0

No evidence available to assess Dogwood Therapeutics, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No sustainability data was available for Dogwood Therapeutics (DWTX) in the provided article, therefore no KPIs could be scored against the Planet-Friendly Business value.

1

Respect for Cultures & Communities

0

No data related to DWTX.US's community engagement, cultural sensitivity, or social responsibility, nor any specific metrics for Respect for Cultures & Communities, are present in the provided article.

1
The article focuses on the company's research and development efforts for therapeutics.
2

Safe & Smart Tech

0

Dogwood Therapeutics has not reported any material cybersecurity attacks.

1
The company maintains a cybersecurity risk management program, overseen by its Audit Committee, which includes intrusion detection systems, continuous monitoring, identity-based access management, and data protection/loss prevention.
2
Employee training on social engineering threats like phishing is conducted twice yearly.
3
The company also performs periodic internal and external risk assessments and compliance audits, supported by third-party vendors, and conducts annual reviews of critical vendor controls, including SOC 2 reports.
4

Zero Waste & Sustainable Products

0

No specific, concrete data points were found in the provided articles regarding Dogwood Therapeutics, Inc.'s performance on any of the Zero Waste & Sustainable Products KPIs. The articles discuss general trends and initiatives within the life sciences and pharmaceutical industries, such as sustainable packaging options, waste reduction programs, and challenges in reducing plastic waste, but do not provide company-specific information for DWTX.US on metrics like waste diversion rates, product recyclability, packaging sustainability, or any other relevant KPI.

Own Dogwood Therapeutics, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.